TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ATYR

aTyr Pharma, Inc.

Healthcare · Biotechnology

0.363$ -3.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ATYR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+2,377.5% -100.0% -96.6% -33.4% -19.1%
-20.8% +4.6% +1,783.1% +23.1% -92.5% +30.0% +61.7% -43.8% +0.8%
-95.9% -33.4% -680.0%
+105.7% +28.2% -32.0% -32.2% -31.1% +23.1% +34.5% +84.0% -1.2% +28.6% +10.8%
+93.5% -3.0% +18.5% +30.1% -7.2% +6.1% +27.7%
+102.2% +22.7% -20.5% -30.9% -70.8% -3.0% +260.5% +68.4% +0.3% +23.3% +11.9%
-16,000,100.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?